AR037505A1 - AN ABSORBENT ARTICLE THAT INCLUDES AN EFFECTIVE AMOUNT OF A FIRST ACTIVE INGREDIENT, A COMPOSITION TO INHIBIT THE EXOPROTEIN PRODUCTION OF GRAMPOSITIVE BACTERIA AND A METHOD TO INHIBIT SUCH EXOPROTEIN PRODUCTION - Google Patents

AN ABSORBENT ARTICLE THAT INCLUDES AN EFFECTIVE AMOUNT OF A FIRST ACTIVE INGREDIENT, A COMPOSITION TO INHIBIT THE EXOPROTEIN PRODUCTION OF GRAMPOSITIVE BACTERIA AND A METHOD TO INHIBIT SUCH EXOPROTEIN PRODUCTION

Info

Publication number
AR037505A1
AR037505A1 ARP020103716A ARP020103716A AR037505A1 AR 037505 A1 AR037505 A1 AR 037505A1 AR P020103716 A ARP020103716 A AR P020103716A AR P020103716 A ARP020103716 A AR P020103716A AR 037505 A1 AR037505 A1 AR 037505A1
Authority
AR
Argentina
Prior art keywords
inhibit
unsaturated aliphatic
aliphatic hydrocarbyl
saturated
effective amount
Prior art date
Application number
ARP020103716A
Other languages
Spanish (es)
Inventor
Worldwide Inc Kimberly-Clark
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/969,299 external-priority patent/US20030135173A1/en
Priority claimed from US09/969,218 external-priority patent/US7026354B2/en
Priority claimed from US09/969,391 external-priority patent/US7022333B2/en
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of AR037505A1 publication Critical patent/AR037505A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Abstract

Se describen artículos absorbentes y no absorbentes. Los artículos incluyen una cantidad efectiva de un compuesto inhibidor aromático para inhibir sustancialmente la producción de exotoxinas por bacterias grampositivas. Los compuestos inhibidores aromáticos de la presente tienen la fórmula general (1), en donde: R1 es seleccionado del grupo que consiste en H, -(O)=COR5, -OR5, -R6C(O)H, -R6OH, -R6COOH, -OR6OH, -OR6COOH, -C(O)NH2, -HNC(O)R5, -(NH2)R7OH, -(NH2)R7COOH, -(NHR8)R7OH, -(NHR8)R7COOH, y NH2 y las sales del mismo; R5 es una mitad de hidrocarbilo alifática saturada o insaturada monovalente, R6 es una mitad de hidrocarbilo alifática saturada o insaturada divalente; R7 es una mitad de hidrocarbilo alifática saturada o insaturada trivalente; R8 es una mitad de hidrocarbilo alifática saturada o insaturada sustituida o no sustituida monovalente la cual puede o no ser interrumpida con heteroátomos; R2, R3 y R4 son seleccionados independientemente del grupo que consiste en H, OH, COOH, y -C(O)R9, R9 es hidrógeno o una mitad de hidrocarbilo alifática saturada o insaturada monovalente.Absorbent and non-absorbent articles are described. The articles include an effective amount of an aromatic inhibitor compound to substantially inhibit the production of exotoxins by gram-positive bacteria. The aromatic inhibitor compounds of the present have the general formula (1), wherein: R1 is selected from the group consisting of H, - (O) = COR5, -OR5, -R6C (O) H, -R6OH, -R6COOH , -OR6OH, -OR6COOH, -C (O) NH2, -HNC (O) R5, - (NH2) R7OH, - (NH2) R7COOH, - (NHR8) R7OH, - (NHR8) R7COOH, and NH2 and salts of the same; R5 is a half of saturated monovalent or unsaturated aliphatic hydrocarbyl, R6 is a half of divalent saturated or unsaturated aliphatic hydrocarbyl; R7 is a trivalent saturated or unsaturated aliphatic hydrocarbyl moiety; R8 is a monovalent substituted or unsubstituted saturated or unsaturated aliphatic hydrocarbyl moiety which may or may not be interrupted with heteroatoms; R2, R3 and R4 are independently selected from the group consisting of H, OH, COOH, and -C (O) R9, R9 is hydrogen or a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety.

ARP020103716A 2001-10-02 2002-10-02 AN ABSORBENT ARTICLE THAT INCLUDES AN EFFECTIVE AMOUNT OF A FIRST ACTIVE INGREDIENT, A COMPOSITION TO INHIBIT THE EXOPROTEIN PRODUCTION OF GRAMPOSITIVE BACTERIA AND A METHOD TO INHIBIT SUCH EXOPROTEIN PRODUCTION AR037505A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/969,299 US20030135173A1 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in absorbent articles using aromatic compositions
US09/969,218 US7026354B2 (en) 2001-10-02 2001-10-02 Aromatic compositions for the inhibition of exoprotein production from gram positive bacteria
US09/969,391 US7022333B2 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in non-absorbent articles uisng aromatic compositions

Publications (1)

Publication Number Publication Date
AR037505A1 true AR037505A1 (en) 2004-11-17

Family

ID=27420759

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020103716A AR037505A1 (en) 2001-10-02 2002-10-02 AN ABSORBENT ARTICLE THAT INCLUDES AN EFFECTIVE AMOUNT OF A FIRST ACTIVE INGREDIENT, A COMPOSITION TO INHIBIT THE EXOPROTEIN PRODUCTION OF GRAMPOSITIVE BACTERIA AND A METHOD TO INHIBIT SUCH EXOPROTEIN PRODUCTION

Country Status (9)

Country Link
EP (1) EP1432459A1 (en)
JP (1) JP2005523239A (en)
KR (1) KR100918887B1 (en)
AR (1) AR037505A1 (en)
AU (1) AU2002336472B2 (en)
BR (1) BR0212679A (en)
CA (1) CA2461291A1 (en)
MX (1) MXPA04002474A (en)
WO (1) WO2003030953A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009007799B4 (en) * 2009-02-06 2010-10-14 ITM Isotopen Technologien München AG Molecule for the functionalization of a carrier, binding of a radionuclide to the carrier and radionuclide generator for the production of the radionuclide and production method
JP2017536893A (en) * 2014-11-27 2017-12-14 イェディテペ・ウニヴェルシテシＹｅｄｉｔｅｐｅ Ｕｎｉｖｅｒｓｉｔｅｓｉ Antibacterial and antiviral hygiene products
EP3520785A4 (en) * 2016-10-09 2020-05-27 Shenzhen Eulikan Biotechnology Co., Ltd. Uses of bacteriostatic agent formula in preparing composition for vaginal use and composition for vaginal use

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317376A (en) * 1963-02-12 1967-05-02 Robert I Schattner Germicidal fabric
IL55214A (en) * 1978-07-25 1981-07-31 Abic Ltd Antibacterial compositions containing trimethoprim and other ingredients
DE3204124A1 (en) * 1982-02-06 1983-08-18 Bayer Ag, 5090 Leverkusen ANTIMYCOTIC TAMPONS WITH HIGH ACTIVE SUBSTANCE RELEASE
US4560549A (en) * 1983-08-24 1985-12-24 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides
GB2186486B (en) * 1986-02-13 1989-11-08 Smith & Nephew Ass Antibacterial dressing
US5180749A (en) * 1989-08-22 1993-01-19 Sterling Winthrop, Inc. Antimicrobial composition
US5476455A (en) * 1993-01-11 1995-12-19 Silber; Arthur L. Toxicity resistant tampon structure
DE4411664A1 (en) * 1994-04-05 1995-10-12 Beiersdorf Ag Novel deodorant and antimicrobial compositions for use in cosmetic or topical preparations
JPH07289575A (en) * 1994-04-27 1995-11-07 Okamoto Ind Inc Rerfume-added condom and method for adding perfume to condom
US5668097A (en) * 1994-08-12 1997-09-16 The Procter & Gamble Company Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces
DE4434781A1 (en) * 1994-09-29 1996-04-04 Beiersdorf Ag Use of fatty acid esters to combat superinfections
DE69623485T2 (en) * 1995-06-07 2003-01-09 Kimberly Clark Co INHIBITATION OF EXOPROTEIN IN ABSORBENT PRODUCTS
JPH09108257A (en) * 1995-10-23 1997-04-28 Shiyouichi Masugi Luminous cream and latex condom
GB9612595D0 (en) * 1996-06-15 1996-08-21 Smithkline Beecham Plc Composition
CA2266070A1 (en) * 1996-09-19 1998-03-26 American Home Products Corporation Method of treating urinary incontinence
CA2287451C (en) * 1997-04-18 2014-06-10 Sean Farmer Topical use of probiotic bacillus spores to prevent or control microbial infections
KR20010013377A (en) * 1997-06-04 2001-02-26 데이비드 엠 모이어 Mild, leave-on antimicrobial compositions
US6353004B1 (en) * 1997-07-14 2002-03-05 Adolor Coporation Peripherally acting anti-pruritic opiates
KR20010034361A (en) * 1998-01-28 2001-04-25 데이비드 엠 모이어 Antimicrobial hydrogel forming absorbent polymers
US6291527B1 (en) * 1998-04-11 2001-09-18 Errekappa Euroterapici S.P.A. Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
FR2777783A1 (en) * 1998-04-24 1999-10-29 Innothera Lab Sa Pharmaceutical composition for treatment of infectious vulvovaginitis and vaginosis
BR9910784A (en) * 1998-05-29 2002-01-29 Kimberly Clark Co Smell reduction device

Also Published As

Publication number Publication date
CA2461291A1 (en) 2003-04-17
EP1432459A1 (en) 2004-06-30
BR0212679A (en) 2005-04-12
MXPA04002474A (en) 2004-05-31
KR100918887B1 (en) 2009-09-23
AU2002336472B2 (en) 2007-08-23
KR20040044950A (en) 2004-05-31
WO2003030953A1 (en) 2003-04-17
JP2005523239A (en) 2005-08-04

Similar Documents

Publication Publication Date Title
HRP20031098B1 (en) Beta-amino tetrahydroimidazo (1,2-a) pyrazines and tetrahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
ES2091180T3 (en) DERIVATIVES FROM ACID 7-PIPERAZINYL- OR 7-MORPHOLINE-4-OXO-QUINOLINO-3-CARBOXYLIC, ITS PREPARATION AND ITS USE AS ANTIMICROBIAL AGENTS.
RS20060699A (en) Isoxazolines for controlling inverterbrate pests
DE602005023901D1 (en) COMPOSITIONS HAVING HIGH ANTIVIRAL AND ANTIBACTERIAL EFFECT
DK1322648T3 (en) 3- (heteroarylacetamido) -2-oxo-azetidine-1-sulfonic acid derivatives as antibacterial agents
NO20060653L (en) Isothiazoloquinolones and related compounds as anti-infective agents
MY102919A (en) Pleuromutilin derivatives process for their preparation and their use.
AR022300A1 (en) ADJUTIVE COMPOSITION
ES2188795T3 (en) BENZOXACINE ANTIMICROBIAL AGENTS.
AR074541A1 (en) NATURAL SILVER DISINFECTANT COMPOSITIONS
AR039936A1 (en) PHARMACEUTICAL FORMULATION OF MODIFIED LIBERATION
PE20030763A1 (en) HIV INTEGRASE INHIBITORS
ES2101252T3 (en) HIV PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF AIDS.
MX9100607A (en) NOVELTY TRICYCLIC COMPOUND OR SALTS OF THE SAME, METHOD TO PRODUCE THE SAME AND ANTIMICROBIAL AGENT THAT CONTAINS IT
GT200100251A (en) PROCEDURE FOR THE PREPARATION OF IMIDAZOTRIAZINONES SUBSTITUTED WITH SULFONAMIDE
AR037505A1 (en) AN ABSORBENT ARTICLE THAT INCLUDES AN EFFECTIVE AMOUNT OF A FIRST ACTIVE INGREDIENT, A COMPOSITION TO INHIBIT THE EXOPROTEIN PRODUCTION OF GRAMPOSITIVE BACTERIA AND A METHOD TO INHIBIT SUCH EXOPROTEIN PRODUCTION
BR0111876B1 (en) process for the preparation of hydroxyphenylcarboxylic acid esters.
WO2003022797A1 (en) Carba-sugar amine derivatives and treatments for disorder of glycolipid metabolism containing the same as the active ingredient
US4447366A (en) Derivatives of lysine and aspartic acid
AR025379A1 (en) 9A-AZALIDAS WITH ANTIBACTERIAL ACTIVITY.
ES2029879T3 (en) PROCEDURE FOR PRODUCING SUBSTITUTED AMINE DERIVATIVES.
AR029002A1 (en) PROCESS FOR PREPARING COMPOUNDS OF QUINOLIN-2-CARBOXYL ACIDS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
AR031712A1 (en) METHOD AND COMPOSITION
MX2012008389A (en) Methods for producing amino-substituted glycolipid compounds.
AR127435A1 (en) PIPERAZINYLSULFONYLARYL COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS

Legal Events

Date Code Title Description
FA Abandonment or withdrawal